Amarantus Bioscience - AMBS - Launching first diagnostic blood test to detect Alzheimer's this year. Partnership currently being finalized. Up-listing to the NASDAQ in 4Q2014.
Currently trading under a dozen pennies.
Read the recent Yahoo news. Company's patented drug, MANF, already has three orphan indications.
Updates from C.E.O. this week.
Twitter: @AmarantusBio .... 10,200 followers.
Can You Spare A Dime?
$AMBS At A Dime
LymPro, first diagnostic blood test to detect Alzheimer's, partnership being finalized. Up-listing later this year.
Substantially over sold.
Read today's Yahoo news.
Twitter: @AmarantusBio .... 10,200 follower.
$AMBS - Launching first blood test to detect Alzheimer's this year. Partnership being finalized.
Up-listing to the NASDAQ in 4Q2014.
Read today's Yahoo news about its patented drug, MANF.
Twitter: @AmarantusBio.... 10,200 followers.
They will have the first blood test to detect early stage Alzheimer's. The global media coverage will be tremendous.
Before the end of the year MNKD will probably have 500M shares in play and no partner.
$AMBS will announce a partner for LymPro before Al announces one for Afrezza. Most likely candidate is JNJ. Amarantus is located at JNJ's incubator Janssen Labs.
$AMBS will hit the .40 range before up-listing in 4Q2014.
A year ago MNKD was at $7.24. $AMBS was under .03. SCOREBOARD!!!
The short list is now Santa Claus, the Easter Bunny, and the Tooth Fairy.
The leprechaun backed out telling Al, "There's no way you're getting your hands on my gold and diluting it to iron pyrite".